Literature DB >> 9509505

Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation.

R Toraldo1, G Canino, C Tolone, M D'Avanzo, B Porfirio, H Hoehn, T Schroeder-Kurth, V Pistoia.   

Abstract

Fanconi's anemia (FA) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by bone marrow failure, congenital abnormalities, chromosome instability, and increased susceptibility to neoplasia. Congenital abnormalities vary in location and in severity and not all patients are affected. Although the primary defect of FA is unknown, hypersensitivity to the clastogenic effect of agents that introduce cross-links in the DNA, such as diepoxybutane (DEB), is a marker of the FA phenotype in patients suffering from aplastic anemia without the physical characteristics of the syndrome and, conversely, in cases with abnormalities in the preanemic phase. We report the case of two dizygotic twins suffering from FA with discordant hematologic data. The DEB test repeated several times in various laboratories yielded conflicting results, whereas cell cycle studies by flow cytometry revealed a pattern typical of FA patients. Moreover, the flow cytometric pattern was correlated with the clinical severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9509505     DOI: 10.3109/08880019809009507

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

2.  Fanconi's anemia in monozygotic twins.

Authors:  Fulton D'Souza; M K Usha; S D Subba Rao
Journal:  Indian J Pediatr       Date:  2007-09       Impact factor: 1.967

3.  Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.

Authors:  Moonjung Jung; Parinda A Mehta; Caroline S Jiang; Rasim O Rosti; Gabriel Usleaman; Joel M Correa da Rosa; Francis P Lach; Erica Goodridge; Arleen D Auerbach; Stella M Davies; Agata Smogorzewska; Farid Boulad
Journal:  Br J Haematol       Date:  2020-08-31       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.